Taken private by Perceptive Advisors in Oct 2024
VAPO - Vapotherm, Inc.
NYSE
->
Healthcare
->
Medical Devices
Exeter,
United States
Type: Equity
VAPO price evolution
VAPO
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $15.53 | $19.11 | $26.82 | $16.85 |
| Short term investments | ||||
| Net receivables | $7.44 | $8.92 | $8.4 | $9.1 |
| Inventory | $23.09 | $25.14 | $28.5 | $32.98 |
| Total current assets | $49.15 | $56.58 | $66.06 | $59.9 |
| Long term investments | ||||
| Property, plant & equipment | $27.46 | $29.12 | $30.7 | $32.44 |
| Goodwill & intangible assets | $0.54 | $0.56 | $0.55 | $0.54 |
| Total noncurrent assets | $31.45 | $33.5 | $34.59 | $36.29 |
| Total investments | ||||
| Total assets | $80.6 | $90.08 | $100.65 | $96.19 |
| Current liabilities | ||||
| Accounts payable | $2.95 | $2.16 | $2.97 | $2.74 |
| Deferred revenue | $1.24 | $1.3 | $1.2 | $1.22 |
| Short long term debt | ||||
| Total current liabilities | $16.19 | $15.12 | $15.98 | $19.56 |
| Long term debt | $104.42 | $101.82 | $99.27 | $96.99 |
| Total noncurrent liabilities | $111.91 | $109.42 | $107.02 | $104.82 |
| Total debt | $104.42 | $101.82 | $99.27 | $96.99 |
| Total liabilities | $128.1 | $124.54 | $123 | $124.39 |
| Shareholders' equity | ||||
| Retained earnings | -$538.01 | -$522.88 | -$508.09 | -$490 |
| Other shareholder equity | -$0.19 | -$0.04 | -$0.02 | -$0.16 |
| Total shareholder equity | -$47.5 | -$34.46 | -$22.35 | -$28.19 |
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $16.85 | $57.32 | $115.54 | $73.51 |
| Short term investments | ||||
| Net receivables | $9.1 | $10.91 | $23.5 | $8.2 |
| Inventory | $32.98 | $36.56 | $19.9 | $9.1 |
| Total current assets | $59.9 | $109.75 | $162.1 | $93.1 |
| Long term investments | ||||
| Property, plant & equipment | $32.44 | $29.2 | $28.8 | $15.1 |
| Goodwill & intangible assets | $0.54 | $19.7 | $21.92 | $0.94 |
| Total noncurrent assets | $36.29 | $50.34 | $53.57 | $18.79 |
| Total investments | ||||
| Total assets | $96.19 | $160.09 | $215.7 | $111.9 |
| Current liabilities | ||||
| Accounts payable | $2.74 | $5.92 | $5 | $2.8 |
| Deferred revenue | $1.22 | $2.08 | $0.46 | $0.14 |
| Short long term debt | $6.61 | $3.49 | ||
| Total current liabilities | $19.56 | $43.17 | $42 | $16.2 |
| Long term debt | $96.99 | $39.73 | $44.5 | $41.8 |
| Total noncurrent liabilities | $104.82 | $50.25 | $59.78 | $41.96 |
| Total debt | $96.99 | $46.33 | $44.54 | $45.28 |
| Total liabilities | $124.39 | $93.42 | $101.8 | $58.2 |
| Shareholders' equity | ||||
| Retained earnings | -$490 | -$376.74 | -$316.9 | -$265.4 |
| Other shareholder equity | -$0.16 | $0.03 | $0.04 | $0.04 |
| Total shareholder equity | -$28.19 | $66.67 | $113.91 | $53.74 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $15.17 | $16.04 | $17.73 | $18.66 |
| Cost of revenue | $9.15 | $9.18 | $11.52 | $13.54 |
| Gross Profit | $6.01 | $6.86 | $6.21 | $5.12 |
| Operating activities | ||||
| Research & development | $3.13 | $3.72 | $3.99 | $4.56 |
| Selling, general & administrative | $12.4 | $13.29 | $15.36 | $16.52 |
| Total operating expenses | $16.28 | $17.02 | $19.84 | $22.83 |
| Operating income | -$10.27 | -$10.16 | -$13.62 | -$17.7 |
| Income from continuing operations | ||||
| EBIT | -$10.28 | -$10.12 | -$13.75 | -$17.73 |
| Income tax expense | $0.02 | $0.03 | $0.01 | -$0.06 |
| Interest expense | $4.83 | $4.64 | $4.33 | $3.77 |
| Net income | ||||
| Net income | -$15.13 | -$14.79 | -$18.09 | -$21.44 |
| Income (for common shares) | -$15.13 | -$14.79 | -$18.09 | -$21.44 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $66.8 | $113.29 | $125.73 | $48.1 |
| Cost of revenue | $49.56 | $60.1 | $62.69 | $26.79 |
| Gross Profit | $17.24 | $53.19 | $63.05 | $21.31 |
| Operating activities | ||||
| Research & development | $20.8 | $18.41 | $16.96 | $13.38 |
| Selling, general & administrative | $73.89 | $91.52 | $89.1 | $56.1 |
| Total operating expenses | $117.63 | $110.35 | $106.06 | $69.47 |
| Operating income | -$100.39 | -$57.16 | -$43.01 | -$48.16 |
| Income from continuing operations | ||||
| EBIT | -$101.61 | -$57.28 | -$46.79 | -$46.11 |
| Income tax expense | $0.01 | -$0.08 | -$0.15 | |
| Interest expense | $11.64 | $2.6 | $4.71 | $5.1 |
| Net income | ||||
| Net income | -$113.26 | -$59.8 | -$51.5 | -$51.06 |
| Income (for common shares) | -$113.26 | -$59.8 | -$51.5 | -$51.06 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | -$15.13 | -$14.79 | -$18.09 | -$21.44 |
| Operating activities | ||||
| Depreciation | $1.62 | $1.54 | $1.64 | $1.63 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.2 | $2.58 | $2.82 | $2.76 |
| Total cash flows from operations | -$2.96 | -$7.35 | -$10.03 | -$10.89 |
| Investing activities | ||||
| Capital expenditures | -$0.55 | -$0.4 | -$1 | -$3.34 |
| Investments | ||||
| Total cash flows from investing | -$0.55 | -$0.4 | -$1 | -$3.34 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.08 | $20.94 | $1.16 | |
| Net borrowings | ||||
| Total cash flows from financing | $0.08 | $20.94 | $1.16 | |
| Effect of exchange rate | -$0.07 | -$0.04 | $0.07 | $0.11 |
| Change in cash and equivalents | -$3.58 | -$7.71 | $9.97 | -$12.97 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$113.26 | -$59.8 | -$51.5 | -$51.06 |
| Operating activities | ||||
| Depreciation | $7.31 | $7.41 | $5.91 | $3.08 |
| Business acquisitions & disposals | -$1.3 | -$8.37 | -$1.56 | |
| Stock-based compensation | $10.38 | $9.77 | $6.43 | $3.84 |
| Total cash flows from operations | -$80.16 | -$55.37 | -$39.47 | -$39.66 |
| Investing activities | ||||
| Capital expenditures | -$11.61 | -$5.89 | -$9.8 | -$4.75 |
| Investments | ||||
| Total cash flows from investing | -$11.61 | -$7.2 | -$18.17 | -$6.31 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.36 | $2.65 | $105.5 | $49.05 |
| Net borrowings | $50.1 | $1.72 | -$5.35 | $10.79 |
| Total cash flows from financing | $51.32 | $4.37 | $99.68 | $59.45 |
| Effect of exchange rate | -$0.03 | -$0.01 | -$0.01 | $0.01 |
| Change in cash and equivalents | -$40.48 | -$58.21 | $42.03 | $13.48 |
News
Fundamentals
| Market cap | $13.32M |
|---|---|
| Enterprise value | $102.22M |
| Shares outstanding | 6.14M |
| Revenue | $67.60M |
|---|---|
| EBITDA | -$45.46M |
| EBIT | -$51.88M |
| Net Income | -$69.44M |
| Revenue Q/Q | 11.97% |
| Revenue Y/Y | -3.96% |
| P/E ratio | -0.19 |
|---|---|
| EV/Sales | 1.51 |
| EV/EBITDA | -2.25 |
| EV/EBIT | -1.97 |
| P/S ratio | 0.20 |
| P/B ratio | -0.28 |
| Book/Share | -7.71 |
| Cash/Share | 2.53 |
| EPS | -$11.31 |
|---|---|
| ROA | -75.58% |
| ROE | 209.65% |
| Debt/Equity | -4.41 |
|---|---|
| Net debt/EBITDA | -2.48 |
| Current ratio | 3.04 |
| Quick ratio | 1.61 |